← Back to Search

Artificial Intelligence

Gixam System for Colorectal Cancer

N/A
Recruiting
Research Sponsored by Jubaan Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days (till pathology report is received)
Awards & highlights
No Placebo-Only Group

Summary

"This trial will test the accuracy of the Gixam™ System in identifying colorectal adenomas compared to traditional colonoscopy. Subjects will have images of their tongue taken with the Gixam™

Who is the study for?
This trial is for individuals scheduled for a routine colonoscopy. They will be asked to participate by having images of their tongue taken with the Gixam™ System, which uses AI to predict the presence of adenomatous polyps in the colon.
What is being tested?
The Gixam™ System's ability to predict colorectal adenomas is being tested. Participants' tongues are imaged and analyzed by AI before they undergo their standard colonoscopy, and results from both methods are compared.
What are the potential side effects?
Since this study involves taking images of the tongue and does not involve drugs or invasive procedures, there are no direct side effects associated with the Gixam™ System itself.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days (till pathology report is received)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days (till pathology report is received) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Primary Efficacy Endpoint - Gixam's diagnostic accuracy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Gixam followed by standard of care colonoscopyExperimental Treatment1 Intervention
This is a single-arm study. All participants will undergo the Gixam test following a standard of care colonoscopy

Find a Location

Who is running the clinical trial?

Jubaan Ltd.Lead Sponsor
2 Previous Clinical Trials
1,200 Total Patients Enrolled
Daniella BleisteinStudy DirectorJubaan Ltd.
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top